Money from the world’s increasingly prosperous technology entrepreneurs has been flooding into biomedical research. Is it ...

Italy: A new study has found that topical finasteride 0.25% monotherapy was associated with significant improvements in hair ...

Where Rare-Disease Treatments Stall Some promising treatments for rare childhood diseases face significant funding gaps before they can reach clinical... Read More ...

Pluri Inc. (Nasdaq, TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions in regenerative medicine and longevity, today announced that Alejandro Weinstein, ...

New injectable and oral options offer eligible men more ways to get proactive about their testosterone health ...

Keeping vaccines and medicines at the right temperature is critical for their efficacy and safety. But this is an often ...

Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the ...

In the event of a heart attack, the affected part of the heart muscle can no longer be supplied with oxygen and nutrients. As ...

The resubmission adds manufacturing data from a new vendor. FDA cited no concerns with OLC’s clinical or preclinical data in ...

Politburo Resolution No. 23-NQ/TW has created opportunities for overseas Vietnamese to contribute directly to national ...

NVIDIA on October 21, 2026, announced a set of healthcare and life sciences collaborations at GTC Berlin, led by the debut of ...

CEOs of smaller ASX biotechs are paying the price of trial failures, regulatory setbacks and difficult capital markets in their ... Read More The post Biocurious: Lifting the lid on ASX life science ...